TREMFYA® PEN
TREMFYA® comes in a single-dose prefilled pen containing one 200 mg dose. Each TREMFYA® PEN can be used only one time.
OR
OR
Write one Rx for TREMFYA® for induction dosing and one Rx for maintenance dosing
Recommended Dosing for Ulcerative Colitis:
Please refer to the full Prescribing Information for the complete dosing information.
Pretreatment Evaluations: Evaluate for tuberculosis (TB) infection, obtain liver enzymes and bilirubin levels, and complete all age-appropriate vaccinations according to current immunization guidelines.1
Monitor: For signs and symptoms of active TB during and after treatment with TREMFYA®; liver enzymes and bilirubin levels for at least 16 weeks of treatment, and periodically thereafter according to routine patient management.1
TREMFYA® is intended for use under the guidance and supervision of a healthcare professional. TREMFYA® may be administered by a healthcare professional, or a patient/caregiver after proper training on correct subcutaneous injection technique.1
IV=intravenous; q4w=every 4 weeks; q8w=every 8 weeks; SC=subcutaneous; SUBQ=subcutaneous.
200 mg/2 mL1
TREMFYA® PEN
Not actual size.
TREMFYA® PEN
TREMFYA® comes in a single-dose prefilled pen containing one 200 mg dose. Each TREMFYA® PEN can be used only one time.
OR
Prefilled syringe
Not actual size.
Prefilled syringe
TREMFYA® comes as a single-dose prefilled syringe containing one 200 mg dose. Each TREMFYA® prefilled syringe can be used only one time.
Also in
100 mg/mL1
TREMFYA® PEN
Not actual size.
TREMFYA® PEN
TREMFYA® comes in a single-dose prefilled pen containing one 100 mg dose. Each TREMFYA® PEN can be used only one time.
OR
Prefilled syringe
Not actual size.
Prefilled syringe
TREMFYA® comes as a single-dose prefilled syringe containing one 100 mg dose. Each TREMFYA® prefilled syringe can be used only one time.
OR
One-Press
Not actual size.
One-Press
TREMFYA® comes in a single-dose One-Press patient-controlled injector containing one 100 mg dose. Each One-Press injector can be used only one time.
Once you have determined the appropriate dose for your patient, you and your patient can choose which device may be best suited for them.1
Please see the full Instructions for Use for the TREMFYA® PEN, One-Press patient-controlled injector, and prefilled syringe.
These videos are not meant to replace the Instructions for Use (IFU) that are supplied with TREMFYA®. Instruct patients to read the IFU before using their TREMFYA® PEN, TREMFYA® prefilled syringe, or One-Press patient-controlled injector and each time they get a refill. Please see the full IFU for TREMFYA®.
TREMFYA® is intended for use under the guidance and supervision of a healthcare professional. TREMFYA® may be administered by a healthcare professional, or a patient/caregiver after proper training on correct subcutaneous injection technique.
References: 1. TREMFYA® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc. 2. Skyrizi® [Prescribing Information]. North Chicago, IL: AbbVie Inc. 3. Omvoh® [Prescribing Information]. Indianapolis, IN: Eli Lilly and Company.